Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by Granulocyte-/Granulocyte-macrophage colony stimulating factors

Molecular Pain

Volumn 9, Issue 1, 2013, Pages

  Bali, Kiran K ^a   Venkataramani, Varun ^a   Satagopam, Venkata P ^b,c   Gupta, Pooja ^a   Schneider, Reinhard ^b,c   Kuner, Rohini ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 2; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; RAC1 PROTEIN; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC REGULATION; GENOME ANALYSIS; HEAT STRESS; IN VITRO STUDY; IN VIVO STUDY; MECHANICAL STRESS; MOUSE; NERVE CELL STIMULATION; NOCICEPTION; NONHUMAN; PAIN; PAIN RECEPTOR; PRIORITY JOURNAL; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

ANIMALS; GANGLIA, SPINAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; SENSORY RECEPTOR CELLS; SIGNAL TRANSDUCTION;

EID: 84884506641     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-9-48     Document Type: Article

References (79)

1. Jimenez-Andrade JM, Mantyh WG, Bloom AP, Ferng AS, Geffre CP, Mantyh PW. Bone cancer pain. Ann N Y Acad Sci 2010, 1198:173-181. 10.1111/j.1749-6632.2009.05429.x, 20536932.
2. Davar G. Endothelin-1 and metastatic cancer pain. Pain Med 2001, 2:24-27. 10.1046/j.1526-4637.2001.002001024.x, 15102314.
3. Grant K, Loizidou M, Taylor I. Endothelin-1: a multifunctional molecule in cancer. Br J Cancer 2003, 88:163-166. 10.1038/sj.bjc.6700750, 2377061, 12610497.
4. Stosser S, Agarwal N, Tappe-Theodor A, Yanagisawa M, Kuner R. Dissecting the functional significance of endothelin A receptors in peripheral nociceptors in vivo via conditional gene deletion. Pain 2009, 148:206-214.
5. Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 2006, 7:797-809.
6. Stosser S, Schweizerhof M, Kuner R. Hematopoietic colony-stimulating factors: new players in tumor-nerve interactions. J Mol Med (Berl) 2011, 89:321-329.
7. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008, 8:533-544. 10.1038/nri2356, 18551128.
8. Schweizerhof M, Stosser S, Kurejova M, Njoo C, Gangadharan V, Agarwal N, Schmelz M, Bali KK, Michalski CW, Brugger S, et al. Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med 2009, 15:802-807. 10.1038/nm.1976, 19525966.
9. Cook AD, Pobjoy J, Sarros S, Steidl S, Durr M, Lacey DC, Hamilton JA. Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain. Ann Rheum Dis 2013, 72:265-270. 10.1136/annrheumdis-2012-201703, 22833372.
10. Cook AD, Pobjoy J, Steidl S, Durr M, Braine EL, Turner AL, Lacey DC, Hamilton JA. Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development. Arthritis Res Ther 2012, 14:R199. 10.1186/ar4037, 3580511, 22995428.
11. Leah E. Experimental arthritis: GM-CSF mediates pain and disease in a mouse model of osteoarthritis. Nat Rev Rheumatol 2012, 8:634.
12. Onuora S. Pain: granulocyte-macrophage colony-stimulating factor required for inflammatory and arthritic pain. Nat Rev Rheumatol 2012, 8:499. 10.1038/nrrheum.2012.139, 22890242.
13. Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci 2004, 117:1281-1283. 10.1242/jcs.00963, 15020666.
14. Boyd TD, Bennett SP, Mori T, Governatori N, Runfeldt M, Norden M, Padmanabhan J, Neame P, Wefes I, Sanchez-Ramos J, et al. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J Alzheimers Dis 2010, 21:507-518.
15. Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 2009, 5:554-559. 10.1038/nrrheum.2009.178, 19798030.
16. Chudin E, Kruglyak S, Baker SC, Oeser S, Barker D, McDaniel TK. A model of technical variation of microarray signals. J Comput Biol 2006, 13:996-1003. 10.1089/cmb.2006.13.996, 16761924.
17. Fu WJ, Hu J, Spencer T, Carroll R, Wu G. Statistical models in assessing fold change of gene expression in real-time RT-PCR experiments. Comput Biol Chem 2006, 30:21-26. 10.1016/j.compbiolchem.2005.10.005, 16321570.
18. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185, 12538238.
19. Simonetti M, Hagenston AM, Vardeh D, Freitag HE, Mauceri D, Lu J, Satagopam VP, Schneider R, Costigan M, Bading H, Kuner R. Nuclear calcium signaling in spinal neurons drives a genomic program required for persistent inflammatory pain. Neuron 2013, 77:43-57. 10.1016/j.neuron.2012.10.037, 23312515.
20. Quick ML, Mukherjee S, Rudick CN, Done JD, Schaeffer AJ, Thumbikat P. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol 2012, 303:R580-R589. 10.1152/ajpregu.00240.2012, 3468445, 22814670.
21. Zhang N, Rogers TJ, Caterina M, Oppenheim JJ. Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol 2004, 173:594-599.
22. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001, 413:203-210. 10.1038/35093019, 11557989.
23. Tulleuda A, Cokic B, Callejo G, Saiani B, Serra J, Gasull X. TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury. Mol Pain 2011, 7:30. 10.1186/1744-8069-7-30, 3095542, 21527011.
24. Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 1997, 386:279-284. 10.1038/386279a0, 9069286.
25. Tao YX. Dorsal horn alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking in inflammatory pain. Anesthesiology 2010, 112:1259-1265. 10.1097/ALN.0b013e3181d3e1ed, 2861149, 20395828.
26. Liou JT, Yuan HB, Mao CC, Lai YS, Day YJ. Absence of C-C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model. Pain 2012, 153:1283-1291. 10.1016/j.pain.2012.03.008, 22494919.
27. Catrina AI, Lampa J, Ernestam S, af Klint E, Bratt J, Klareskog L, Ulfgren AK. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford) 2002, 41:484-489.
28. Green MJ, Gough AK, Devlin J, Smith J, Astin P, Taylor D, Emery P. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2003, 42:83-88.
29. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007, 356:319-350.
30. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, Park JS, Cho HJ. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 2004, 19:3375-3381. 10.1111/j.0953-816X.2004.03441.x, 15217394.
31. Tan AM, Stamboulian S, Chang YW, Zhao P, Hains AB, Waxman SG, Hains BC. Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. J Neurosci 2008, 28:13173-13183. 10.1523/JNEUROSCI.3142-08.2008, 19052208.
32. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004, 101:7618-7623. 10.1073/pnas.0307512101, 419655, 15128949.
33. Chattopadhyay S, Myers RR, Janes J, Shubayev V. Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav Immun 2007, 21:561-568. 10.1016/j.bbi.2006.10.015, 2865892, 17189680.
34. Ji RR, Xu ZZ, Wang X, Lo EH. Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci 2009, 30:336-340. 10.1016/j.tips.2009.04.002, 2706286, 19523695.
35. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331-336. 10.1038/nm1723, 2279180, 18264108.
36. Kular L, Rivat C, Lelongt B, Calmel C, Laurent M, Pohl M, Kitabgi P, Melik-Parsadaniantz S, Martinerie C. NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9. J Neuroinflammation 2012, 9:36. 10.1186/1742-2094-9-36, 3332238, 22353423.
37. Kunz S, Niederberger E, Ehnert C, Coste O, Pfenninger A, Kruip J, Wendrich TM, Schmidtko A, Tegeder I, Geisslinger G. The calpain inhibitor MDL 28170 prevents inflammation-induced neurofilament light chain breakdown in the spinal cord and reduces thermal hyperalgesia. Pain 2004, 110:409-418. 10.1016/j.pain.2004.04.031, 15275793.
38. Xie W, Uchida H, Nagai J, Ueda M, Chun J, Ueda H. Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain. J Neurochem 2010, 113:1002-1011. 10.1111/j.1471-4159.2010.06664.x, 2908211, 20420580.
39. Abram SE, Yi J, Fuchs A, Hogan QH. Permeability of injured and intact peripheral nerves and dorsal root ganglia. Anesthesiology 2006, 105:146-153. 10.1097/00000542-200607000-00024, 16810006.
40. Dogrul A, Gul H, Yesilyurt O, Ulas UH, Yildiz O. Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice. Acta Diabetol 2011, 48:135-142. 10.1007/s00592-010-0237-x, 21104419.
41. Shubayev VI, Myers RR. Anterograde TNF alpha transport from rat dorsal root ganglion to spinal cord and injured sciatic nerve. Neurosci Lett 2002, 320:99-101. 10.1016/S0304-3940(02)00010-1, 11849773.
42. Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, Scherbakov N, Davis JB, Bluethmann H, Ji RR, Kress M. Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci 2008, 28:5072-5081. 10.1523/JNEUROSCI.4476-07.2008, 18463260.
43. Sandborn WJ, Hanauer SB, Katz S, Safdi M, Wolf DG, Baerg RD, Tremaine WJ, Johnson T, Diehl NN, Zinsmeister AR. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2001, 121:1088-1094. 10.1053/gast.2001.28674, 11677200.
44. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000, 342:763-769. 10.1056/NEJM200003163421103, 10717011.
45. Cuellar JM, Montesano PX, Carstens E. Role of TNF-alpha in sensitization of nociceptive dorsal horn neurons induced by application of nucleus pulposus to L5 dorsal root ganglion in rats. Pain 2004, 110:578-587. 10.1016/j.pain.2004.03.029, 15288398.
46. Czeschik JC, Hagenacker T, Schafers M, Busselberg D. TNF-alpha differentially modulates ion channels of nociceptive neurons. Neurosci Lett 2008, 434:293-298. 10.1016/j.neulet.2008.01.070, 18314270.
47. Erschbamer MK, Hofstetter CP, Olson L. RhoA, RhoB, RhoC, Rac1, Cdc42, and Tc10 mRNA levels in spinal cord, sensory ganglia, and corticospinal tract neurons and long-lasting specific changes following spinal cord injury. J Comp Neurol 2005, 484:224-233. 10.1002/cne.20471, 15736231.
48. Nakayama AY, Harms MB, Luo L. Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons. J Neurosci 2000, 20:5329-5338.
49. Tashiro A, Minden A, Yuste R. Regulation of dendritic spine morphology by the rho family of small GTPases: antagonistic roles of Rac and Rho. Cereb Cortex 2000, 10:927-938. 10.1093/cercor/10.10.927, 11007543.
50. Tashiro A, Yuste R. Regulation of dendritic spine motility and stability by Rac1 and Rho kinase: evidence for two forms of spine motility. Mol Cell Neurosci 2004, 26:429-440. 10.1016/j.mcn.2004.04.001, 15234347.
51. Woessner JF. The family of matrix metalloproteinases. Ann N Y Acad Sci 1994, 732:11-21. 10.1111/j.1749-6632.1994.tb24720.x, 7978784.
52. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002, 39:279-291. 10.1002/glia.10108, 12203394.
53. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004, 4:617-629. 10.1038/nri1418, 15286728.
54. Yong VW. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005, 6:931-944. 10.1038/nrn1807, 16288297.
55. Demestre M, Wells GM, Miller KM, Smith KJ, Hughes RA, Gearing AJ, Gregson NA. Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration. Neuroscience 2004, 124:767-779. 10.1016/j.neuroscience.2003.12.037, 15026117.
56. Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 1998, 121(Pt 12):2327-2334.
57. Li G, Iyengar R. Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta -catenin-regulated cell proliferation. Proc Natl Acad Sci USA 2002, 99:13254-13259. 10.1073/pnas.202355799, 130620, 12239346.
58. Neumar RW, Xu YA, Gada H, Guttmann RP, Siman R. Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J Biol Chem 2003, 278:14162-14167. 10.1074/jbc.M212255200, 12576481.
59. Saito Y, Saido TC, Sano K, Kawashima S. The calpain-calpastatin system is regulated differently during human neuroblastoma cell differentiation to Schwannian and neuronal cells. FEBS Lett 1994, 353:327-331. 10.1016/0014-5793(94)01075-7, 7957886.
60. Vanderklish PW, Krushel LA, Holst BH, Gally JA, Crossin KL, Edelman GM. Marking synaptic activity in dendritic spines with a calpain substrate exhibiting fluorescence resonance energy transfer. Proc Natl Acad Sci USA 2000, 97:2253-2258. 10.1073/pnas.040565597, 15787, 10688895.
61. Chera B, Schaecher KE, Rocchini A, Imam SZ, Ray SK, Ali SF, Banik NL. Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Ann N Y Acad Sci 2002, 965:274-280.
62. Baliova M, Betz H, Jursky F. Calpain-mediated proteolytic cleavage of the neuronal glycine transporter, GlyT2. J Neurochem 2004, 88:227-232.
63. Chan SL, Mattson MP. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999, 58:167-190. 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K, 10491581.
64. Banik NL, Matzelle D, Gantt-Wilford G, Hogan EL. Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury. Ann N Y Acad Sci 1997, 825:120-127. 10.1111/j.1749-6632.1997.tb48421.x, 9369980.
65. Kampfl A, Posmantur RM, Zhao X, Schmutzhard E, Clifton GL, Hayes RL. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J Neurotrauma 1997, 14:121-134. 10.1089/neu.1997.14.121, 9104930.
66. Shields DC, Banik NL. Putative role of calpain in the pathophysiology of experimental optic neuritis. Exp Eye Res 1998, 67:403-410. 10.1006/exer.1998.0537, 9820787.
67. Leung L, Cahill CM. TNF-alpha and neuropathic pain-a review. J Neuroinflammation 2010, 7:27. 10.1186/1742-2094-7-27, 2861665, 20398373.
68. Zheng W, Ouyang H, Zheng X, Liu S, Mata M, Fink DJ, Hao S. Glial TNFalpha in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain 2011, 7:40. 10.1186/1744-8069-7-40, 3121595, 21599974.
69. Niederberger E, Geisslinger G. The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy?. FASEB J 2008, 22:3432-3442. 10.1096/fj.08-109355, 18559989.
70. Fernyhough P, Smith DR, Schapansky J, Van Der Ploeg R, Gardiner NJ, Tweed CW, Kontos A, Freeman L, Purves-Tyson TD, Glazner GW. Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons. J Neurosci 2005, 25:1682-1690. 10.1523/JNEUROSCI.3127-04.2005, 15716404.
71. Pollock G, Pennypacker KR, Memet S, Israel A, Saporta S. Activation of NF-kappaB in the mouse spinal cord following sciatic nerve transection. Exp Brain Res 2005, 165:470-477. 10.1007/s00221-005-2318-6, 15912368.
72. Kanngiesser M, Haussler A, Myrczek T, Kusener N, Lim HY, Geisslinger G, Niederberger E, Tegeder I. Inhibitor kappa B kinase beta dependent cytokine upregulation in nociceptive neurons contributes to nociceptive hypersensitivity after sciatic nerve injury. J Pain 2012, 13:485-497. 10.1016/j.jpain.2012.02.010, 22564672.
73. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003, 22:8543-8567. 10.1038/sj.onc.1207107, 14634618.
74. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001, 3:E255-E263. 10.1038/ncb1101-e255, 11715037.
75. Moore JD, Rothwell NJ, Gibson RM. Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent. Br J Pharmacol 2002, 135:1069-1077. 10.1038/sj.bjp.0704538, 1573202, 11861336.
76. Sugimoto T, Bennett GJ, Kajander KC. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine. Pain 1990, 42:205-213. 10.1016/0304-3959(90)91164-E, 2247318.
77. Whiteside GT, Munglani R. Cell death in the superficial dorsal horn in a model of neuropathic pain. J Neurosci Res 2001, 64:168-173. 10.1002/jnr.1062, 11288144.
78. Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, Moore KA, Decosterd I, Coggeshall RE, Woolf CJ. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 2005, 25:7317-7323. 10.1523/JNEUROSCI.1526-05.2005, 16093381.
79. Joseph EK, Levine JD. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 2004, 20:2896-2902. 10.1111/j.1460-9568.2004.03750.x, 15579143.